Alison D. Marshall

2.4k total citations
47 papers, 1.2k citations indexed

About

Alison D. Marshall is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Alison D. Marshall has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 29 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Alison D. Marshall's work include Hepatitis C virus research (29 papers), HIV, Drug Use, Sexual Risk (25 papers) and Hepatitis B Virus Studies (16 papers). Alison D. Marshall is often cited by papers focused on Hepatitis C virus research (29 papers), HIV, Drug Use, Sexual Risk (25 papers) and Hepatitis B Virus Studies (16 papers). Alison D. Marshall collaborates with scholars based in Australia, United States and Canada. Alison D. Marshall's co-authors include Jillian Panuzio, Casey T. Taft, Jason Grebely, Carla Treloar, Gregory J. Dore, Behzad Hajarizadeh, Sahar Bajis, Tanya Applegate, F. Lamoury and Julie Smith and has published in prestigious journals such as Clinical Infectious Diseases, Social Science & Medicine and The Journal of Infectious Diseases.

In The Last Decade

Alison D. Marshall

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alison D. Marshall Australia	17	651	596	216	150	130	47	1.2k
Paul K Nelson Australia	10	956 1.5×	741 1.2×	201 0.9×	117 0.8×	50 0.4×	14	1.4k
Emran Mohammad Razzaghi Iran	9	314 0.5×	83 0.1×	185 0.9×	70 0.5×	46 0.4×	14	649
V. Anna Gyarmathy United States	24	963 1.5×	241 0.4×	126 0.6×	11 0.1×	80 0.6×	73	1.4k
Marcel Buster Netherlands	15	340 0.5×	56 0.1×	184 0.9×	28 0.2×	32 0.2×	44	795
Jeffrey J. Weiss United States	15	225 0.3×	153 0.3×	253 1.2×	39 0.3×	16 0.1×	44	806
Chun Bong Chow Hong Kong	19	168 0.3×	57 0.1×	311 1.4×	56 0.4×	21 0.2×	52	1.1k
Mindy Sobota United States	12	377 0.6×	41 0.1×	70 0.3×	38 0.3×	36 0.3×	20	668
Amy Jo Harzke United States	15	359 0.6×	59 0.1×	302 1.4×	104 0.7×	7 0.1×	22	855
Barbara Coughlan Ireland	17	187 0.3×	155 0.3×	145 0.7×	54 0.4×	9 0.1×	58	845
Greta Kilmer United States	13	114 0.2×	36 0.1×	361 1.7×	29 0.2×	25 0.2×	37	822

Countries citing papers authored by Alison D. Marshall

Since Specialization

Citations

This map shows the geographic impact of Alison D. Marshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison D. Marshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison D. Marshall more than expected).

Fields of papers citing papers by Alison D. Marshall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison D. Marshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison D. Marshall. The network helps show where Alison D. Marshall may publish in the future.

Co-authorship network of co-authors of Alison D. Marshall

This figure shows the co-authorship network connecting the top 25 collaborators of Alison D. Marshall. A scholar is included among the top collaborators of Alison D. Marshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison D. Marshall. Alison D. Marshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conway, Anna, Alison D. Marshall, Jason Grebely, Guillaume Fontaine, & Carla Treloar. (2025). Professional identities and new technologies of hepatitis C point-of-care testing. Social Science & Medicine. 378. 118140–118140. 1 indexed citations

Lafferty, Lise, Carla Treloar, Evan B. Cunningham, et al.. (2025). Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection. International Journal of Drug Policy. 137. 104720–104720. 1 indexed citations

Marshall, Alison D., et al.. (2024). Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study. International Journal of Drug Policy. 129. 104477–104477.

Valerio, Heather, Alison D. Marshall, Anna Conway, et al.. (2024). Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study. International Journal of Drug Policy. 127. 104394–104394.

Conway, Anna, Alison D. Marshall, Sione Crawford, et al.. (2023). Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study. Implementation Science. 18(1). 22–22. 1 indexed citations

Valerio, Heather, Maryam Alavi, Alison D. Marshall, et al.. (2023). Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study. Drug and Alcohol Review. 43(5). 1080–1092. 5 indexed citations

Marshall, Alison D., Sophia Schroeder, Lise Lafferty, et al.. (2023). Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study. Journal of Substance Use and Addiction Treatment. 150. 209066–209066. 5 indexed citations

Marshall, Alison D., et al.. (2023). Universal hepatitis C virus screening and treatment as part of prenatal care. The Lancet. Gastroenterology & hepatology. 8(4). 295–297. 4 indexed citations

Ginley, Meredith K., Shalini Arunogiri, Michael Christmass, et al.. (2023). Perspectives and sentiments on contingency management from people who use methamphetamine. Drug and Alcohol Review. 42(6). 1427–1437. 4 indexed citations

10.

Conway, Anna, Noa Krawczyk, Alison D. Marshall, et al.. (2023). Typology of laws restricting access to methadone treatment in the United States: A latent class analysis. International Journal of Drug Policy. 119. 104141–104141. 15 indexed citations

11.

Cheng, Qinglu, Sahar Bajis, Evan B. Cunningham, et al.. (2023). Health-related quality of life among people who inject drugs in Australia. Quality of Life Research. 32(11). 3195–3207. 3 indexed citations

12.

Cunningham, Evan B., Alice Wheeler, Behzad Hajarizadeh, et al.. (2022). Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy. 111. 103917–103917. 31 indexed citations

13.

Lafferty, Lise, Sophia Schroeder, Alison D. Marshall, et al.. (2022). Trust and service engagement among people who inject drugs after release from prison. International Journal of Drug Policy. 111. 103925–103925. 3 indexed citations

14.

Marshall, Alison D., Jake Rance, Jason Grebely, & Carla Treloar. (2022). ‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective. International Journal of Drug Policy. 102. 103610–103610. 10 indexed citations

15.

Larney, Sarah, Annie Madden, Alison D. Marshall, Natasha K. Martin, & Carla Treloar. (2022). A gender lens is needed in hepatitis C elimination research. International Journal of Drug Policy. 103. 103654–103654. 12 indexed citations

16.

Marshall, Alison D., Max Hopwood, Jason Grebely, & Carla Treloar. (2020). Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation. International Journal of Drug Policy. 86. 102964–102964. 9 indexed citations

17.

Neale, Joanne, Charlotte N. E. Tompkins, Alison D. Marshall, Carla Treloar, & John Strang. (2018). Do women with complex alcohol and other drug use histories want women‐only residential treatment?. Addiction. 113(6). 989–997. 27 indexed citations

18.

Marshall, Alison D., Jason Grebely, Gregory J. Dore, & Carla Treloar. (2017). ‘I didn’t want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study. International Journal of Drug Policy. 47. 153–160. 9 indexed citations

19.

Marshall, Alison D., Sahar Saeed, Lisa Barrett, et al.. (2016). Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ Open. 4(4). E605–E614. 61 indexed citations

20.

Marshall, Alison D., Michelle Micallef, Joanne Telenta, et al.. (2015). Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study. International Journal of Drug Policy. 26(10). 984–991. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact